The Immune Tolerance Network (or ITN) is a non-profit, government-funded consortium of researchers working together to establish new treatments for diseases of the immune system. The ITN conducts clinical trials of specialized immune tolerance therapies in the following areas:
As well, each ITN clinical trial includes a coordinated set of laboratory studies of the genetic, cellular and immunological mechanisms behind the experimental treatment. These studies are designed to help find out how the body reacts to the treatment, and to find better ways of measuring immune tolerance in the immune system.
The ITN is led by a consortium of some of the world's foremost authorities on immune tolerance - doctors, basic and clinical researchers and technology professionals from academia, government and industry.
The ITN was founded in 1999 by the National Institute of Allergy and Infectious Diseases (a part of the National Institutes of Health ) and receives support from the National Institute of Diabetes and Digestive and Kidney Diseases and the Juvenile Diabetes Research Foundation .
